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Tao-Hong-Si-Wu-Tang (THSWT) is a famous traditional Chinese medicine (TMC). In the present study, oral administration
of THSWT (0.7 and 1.4g kg
−1day
−1) for 14 days before MCAO dose-dependently attenuated focal cerebral ischemia in rats.
MCAO-induced focal cerebral ischemia was associated with increases in hypoxia-inducible factor (HIF)-1α, inducible nitric oxide
synthase (iNOS), tumor necrosis factor (TNF)-α, and active caspase-3 expressions in ischemic regions. These expressions were
obviously inhibited by 0.7g kg
−1day
−1 THSWT treatment. In addition, THSWT inhibited platelet aggregation stimulated by
collagen in washed platelets. In an in vivo study, THSWT (16g kg
−1) signiﬁcantly prolonged platelet plug formation in mice.
However, THSWT (20 and 40μgm L
−1) did not signiﬁcantly reduce the electron spin resonance (ESR) signal intensity of hydroxyl
radical (OH
•) formation. In conclusion, the most important ﬁndings of this study demonstrate for the ﬁrst time that THSWT
possesses potent neuroprotective activity against MCAO-induced focal cerebral ischemia in vivo. This eﬀect may be mediated, at
least in part, by the inhibition of both HIF-1α and TNF-α activation, followed by the inhibition of inﬂammatory responses (i.e.,
iNOS expression), apoptosis formation (active caspase-3), and platelet activation, resulting in a reduction in the infarct volume in
ischemia-reperfusion brain injury.
1.Introduction
Ischemic brain injury often causes irreversible brain damage.
Thecascadeofeventsleadingtoneuronalinjuryanddeathin
ischemia includes the release of cytokines, free radicals, and
platelet activation [1, 2]. Reperfusion of ischemic areas can
exacerbate ischemic brain damage through the generation of
reactive oxygen species (ROS) including superoxide anions
(O
·−
2 ), hydroxyl radicals (OH
·), and nitric oxide (NO) [3, 4].
Leukocytes are a potential source of ROS when activated
during inﬂammatory responses [5]. When a tissue suﬀers
from ischemia and reperfusion, proinﬂammatory cytokines
produced by inﬂammatory cells can trigger adhesion and
migration of circulating leukocytes to endothelial cells
and generation of ROS that enhances ischemic injury [6].
Furthermore, ROS also mediate a mitochondrial signaling
pathway that may lead to apoptosis followed by cerebral
ischemia [4]. Therefore, both the inhibition of production
and enhanced degradation of ROS by pharmacological
agents were found to limit the extent of brain damage fol-
lowing stroke-like events [7]. Furthermore, the participation
of activated platelets was observed in brain microvessels
of the ischemic microvascular bed after experimental mid-
dle cerebral artery occlusion (MCAO) [2]. Microvascular
thrombi continue to accumulate even after recanalization
of the MCAO, contributing to postischemic hypoperfusion
andongoingneuronaldamage[8].Thus,plateletaggregation
may play a crucial role in MCAO-induced cerebral damage.
Traditional Chinese medicines (TCMs) have successfully
been used for centuries to treat a wide variety of ailments2 Evidence-Based Complementary and Alternative Medicine
and have attracted increasing attention from industry and
academia in China [9, 10]. However, their therapeutic mech-
anisms and eﬀects are still not well understood. Nowadays,
it is widely accepted that multiple ingredients are responsible
for the therapeutic eﬀects of TMCs. For example, Tao-Hong-
Si-Wu-Tang(THSWT)isafamousTMCformulafortreating
cardiovascular diseases (CVDs) with a history of several
centuries. The formula mainly consists of six plant materials:
Shu Di Huang (Rehmannia glutinosa Liboschitz), Bai Shao
(Paeonia lactiﬂora Pallas), Dang Gui (Angelica sinensis (Oliv.)
Diels), Chuan Xiong (Ligusticum chuanxiong Hort.),T a oR e n
(Prunus persica (L.) Batsch.), and Hong Hua (Carthamus
tinctorius L). To treat ischemic stroke, TCM practitioners
prescribe herbs that can open the blood vessels and promote
blood ﬂow in circulation. THSWT has long been employed
clinically to promote blood circulation to relieve women’s
irregular menses disorder, and is also used to treat CVDs
such as hypertension and angina [11, 12]. Furthermore,
it can increase blood ﬂow of the microcirculation thereby
regulating diabetic neuropathies and glucocorticoid-induced
avascular necrosis of the femoral head [13, 14].
Hitherto, research tended to report on the advantages of
THSWTintreatingsomeCVDs;however,thereisnosystem-
atic evaluation of the treatment of ischemic stroke. Hence,
this study investigated the therapeutic milieu of THSWT in
MCAO-induced cerebral infarction, and the ﬁndings were
utilized to further characterize the neuroprotective potential
of THSWT.
2. Methods
2.1.MCAO-InducedTransientFocalCerebralIschemiainRats.
Male Wistar rats (250∼300g) were used in this study. All
animal experiments and care were performed according to
the National Research Council Guide for the Care and Use of
Laboratory Animals and was approved by the Institutional
Animal Care and Use Committee (IACUC) of Taipei Medical
University (no. LAC-98-0088). Before undergoing the exper-
imental procedures, all animals were clinically normal, were
free of apparent infection or inﬂammation and exhibit no
neurological deﬁcits which were evaluated by spontaneous
rotational test.
Animals were anesthetized with a mixture of 75% air
and 25%O2 gases containing 3% isoﬂurane. The rectal
temperature was maintained at 37±0.5◦C. The right middle
cerebral artery (MCA) was occluded as described in our
previous report [15]. Brieﬂy, the right common carotid
artery (CCA) was exposed, and a 4–0 monoﬁlament nylon
thread (25mm) coated with silicon was then inserted from
the external into the internal carotid artery until the tip
occluded the origin of the MCA. After closure of the
operative sites, the animals were allowed to wake from
the anesthesia. During another brief period of anesthesia,
the ﬁlament was gently removed after 1h of MCAO. An
observer blinded to the identity of the groups assessed the
neurological deﬁcits at 1 and 24h after reperfusion (before
being euthanized) by forelimb akinesia (also called the
postural tail-hang) test whereasa spontaneous rotational test
wasusedasacriterionforevaluatingtheischemicinsult[16].
Animals not showing behavioral deﬁcits at the above time
pointsafterreperfusionwereexcludedfromthestudy.Onthe
otherhand,reperfusionwasalsoensuredbyanimprovement
in ipsilateral local blood ﬂow to at least 60% of the baseline
following an initial sharp decrease to about 50% ∼ 60%
of the baseline caused by MCAO as determined using a
continuous laser Doppler ﬂowmeter (LDF; Oxford Array,
Oxford Optronix, Oxford, UK) with a standard needle probe
(pp-051).
Rats were euthanized by decapitation after 24h of
reperfusion. The brains were cut into 2-mm coronal slices
starting 1mm from the frontal pole. Each stained brain (2%
2,3,5-triphenyltetrazolium; TTC) slice was drawn using a
computerized image analyzer (Image-Pro plus). The calcu-
lated infarct areas were then compiled to obtain the infarct
volume (mm3) per brain. Infarct volumes were expressed
as a percentage of the contralateral hemisphere volume
using the formula: (the area of the intact contralateral [left]
hemisphere—the area of the intact region of the ipsilateral
[right] hemisphere) to compensate for edema formation in
the ipsilateral hemisphere [15].
All animals were divided into three groups: (1) a
sham-operated group (2) a group orally treated with an
isovolumetric solvent (distilled water) and (3) groups orally
treated with 0.7 and 1.4gkg
−1day
−1 THSWT for 14 days,
respectively. The THSWT was obtained from the Sun Ten
Pharm. CO. (Taichung, Taiwan). Its composition and purity
is as follows: Shu Di Huang 5.0g, Bai Shao 5.0g, Dang Gui
5 . 0g ,C h u a nX i o n g2 . 5g ,T a oR e n5 . 0g ,a n dH o n gH u a2 . 5g .
The above herbal mixtures (25g) yield an amount of dry
extract 7.0g (25.0:7 .0 = 3.6 : 1). Each 12g contains 7g
of herbal extract and 5g of corn starch.
2.2. Neurobehavioral Test. The sensorimotor integrity was
conducted to assess the neurobehavior at 24h after MCAO
in rats [16]. Five categories of motor neurological ﬁndings
were scored: 0, no observable deﬁcit; 1, forelimb ﬂexion; 2,
forelimb ﬂexion and decreased resistance to lateral push; 3,
forelimb ﬂexion, decreased resistance to lateral push, and
unilateral circling; 4, forelimb ﬂexion, unable or diﬃcult to
ambulate.
2.2.1. Determination of the Expressions of Hypoxia-Inducible
Factor (HIF)-1α, Inducible Nitric Oxide Synthase (iNOS),
Tumor Necrosis Factor (TNF)-α, and Active Caspase-3 in
MCAO-Insulted Brains. Expressions of HIF-1α,i N O S ,T N F -
α, and active caspase-3 in the brain at 24h after MCAO-
reperfusion injury were analyzed by immunoblotting as
described by Rodrigo et al. [17] with minor modiﬁcations.
MCAO-insulted and sham-operated rats were anesthetized
with chloral hydrate (400mgkg−1, i.p.), then the apex
of the heart was penetrated with a perfusion cannula
inserted through the left ventricle into the ascending aorta.
Perfusion with ice-cold phosphate-buﬀered saline (PBS) was
performed, and an incision was made in the right atrium for
venous drainage. Brains were freshly removed and sectioned
coronally into four sequential parts from the frontal lobeEvidence-Based Complementary and Alternative Medicine 3
to the occipital lobe. The third of four parts of the right
hemisphere was separately collected, snap-frozen in liquid
nitrogen,andstoredat −70
◦C.Thefrozentissueswereplaced
in homogenate buﬀer and homogenized, then sonicated for
10s three times at 4◦C. The sonicates were subjected to
centrifugation (10,000×g).
The supernatant (50μg protein) was subjected to sodium
dodecylsulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and electrophoretically transferred to polyvinyli-
dene diﬂuoride (PVDF) membranes (0.45μm, Hybond-P,
Amersham). After incubation in blocking buﬀer and being
washed three times with TBST buﬀer (10mM Tris-base,
100mM NaCl, and 0.1% Tween 20; pH 7.5), the blots
were treated with an anti-HIF-1α polyclonal antibody (pAb,
1:1000; R&D,Minneapolis, MN),ananti-iNOS monoclonal
antibody (mAb; 1:3000, BD Biosciences, San Jose, CA), an
anti-TNF-α pAb (1:1000; Cell Signaling, Beverly, MA), and
an anti-active caspase-3 pAb (1:250; Biovision, Mountain
View, CA), or an anti-α-tubulin mAb (1:2000; Santa
Cruz Biotech, Santa Cruz, CA) in TBST buﬀer overnight.
Blots were subsequently washed with TBST and incubated
with a secondary horseradish peroxidase-conjugated goat
antimouse mAb or donkey anti-rabbit immunoglobulin G
(IgG) (Amersham) for 1h. Blots were then washed, and the
immunoreactive protein was detected using ﬁlm exposed
to enhanced chemiluminescence detection reagents (ECL+
system; Amersham). The bar graph depicts the ratios of
semiquantitative results obtained by scanning reactive bands
and quantifying the optical density using Videodensitometry
(Bio-1D vers. 99 image software).
2.3. Platelet Aggregation. Human platelet suspensions were
prepared as previously described [18]. This study was
approved by the Institutional Review Board (IRB) of Taipei
Medical University (no. P960312) and conformed to the
principles outlined in the Helsinki Declaration,a n da l l
human volunteers provided informed consent. In brief,
blood was collected from healthy human volunteers who
had taken no medicine during the preceding 2 weeks,
and was mixed with acid/citrate/glucose (9:1:1, v v−1).
After centrifugation, the supernatant (platelet-rich plasma;
PRP) was supplemented with prostaglandin E1 (0.5μM)
and heparin (6.4IUmL−1) and centrifuged for 10min. The
washed platelets were ﬁnally suspended in Tyrode’s solution
containing BSA (3.5mgmL
−1)a n da d j u s t e dt oa b o u t4 .5 ×
108 platelets mL
−1. The ﬁnal concentration of Ca2+ in
Tyrode’s solution was 1mM. A turbidimetric method was
applied to measure platelet aggregation [18], using a Lumi-
Aggregometer (Payton, Scarborough, Ontario, Canada).
Washed platelet suspensions (3.6 × 108 platelets mL
−1)w e r e
preincubated with various concentrations of THSWT or an
isovolumetric solvent control (Tyrode’s solution) for 3min
before the addition of agonists. The reaction was allowed
to proceed for 6min, and the extent of aggregation was
expressed in light-transmission units.
2.4. Fluorescein Sodium-Induced Platelet Thrombi in Mesen-
teric Microvessels of Mice. This study conformed to the
Guide for the Care and Use of Laboratory Animals (NIH
Publication no. 85–23, 1996). As described previously [15],
mice were anesthetized, and an external jugular vein was
cannulated with PE-10 for administration of the dye and
drugs. A segment of the small intestine was placed onto
a transparent culture dish for microscopic observation.
Venules (30∼40μm) were selected for irradiation to produce
a microthrombus. Filtered light from which wavelengths
below 520nm had been eliminated was used to irradiate a
microvessel.TwodosesofTHSWT(3.2and16mgkg
−1)were
administered 1min after ﬂuorescein sodium (15μgkg
−1)
had been given. The time lapse for inducing thrombus
formation leading to cessation of blood ﬂow was measured.
2.5.ElectronSpinResonance(ESR)Spectrometry. ESRspectra
were recorded on a Bruker EMX ESR spectrometer using a
quartz ﬂat cell designed for aqueous solutions. Conditions
of ESR spectrometry were as follows: 3456 ± 50G power of
0.635Mw, a modulation frequency of 100kHz; a frequency
of 9.663GHz; a modulation amplitude of 1G; receiver gain
of 6.3 × 10
−4, a time constant of 81.92ms, and a conversion
time of 327.68ms. The ESR spectrum was obtained in the
H2O2/NaOH/DMSO system as previously described [19].
Brieﬂy, 100μL of DMSO and the same volumes of 25mM
NaOHandTHSWT(20and40μgmL
−1)weremixedinatest
tube, followed by the addition of 10μL DMPO and 100μL
of 30%H2O2. The reaction mixture was aspirated into a
quartz ﬂat cell and set in the ESR apparatus; scanning began
1min after all reagents were mixed. The rate of free radical-
scavenging activity was deﬁned by the following equation:
inhibition rate = 1[signal height (THSWT) signal height−1
(solvent control)] [19].
2.6. Data Analysis. Experimental results are expressed as the
means ± S.E.M. a n da r ea c c o m p a n i e db yt h en u m b e ro f
observations. Paired Student’s t-test was used to determine
signiﬁcant diﬀerences in the in vivo study of platelet plug
formation. The other experiments were assessed by the
method of analysis of variance (ANOVA). If this analysis
indicated signiﬁcant diﬀerences among the group means,
then each group was compared using the Newman-Keuls
method. A P value of <.05 was considered statistically
signiﬁcant.
3. Results
3.1. Reduction of MCAO-Induced Focal Cerebral Ischemia by
THSWT in Rats. All animals in this study showed similar
physiological values (i.e., rectal temperature and mean arte-
rial blood pressure) before, during, and after MCAO among
the groups (data not shown). Neither abnormal behavior,
depression of respiration, nor hypothermia was observed in
the solvent- or THSWT-treated groups. The cerebral infarc-
tion was examined using 2-mm-thick slices of the cerebrum
24h after MCAO reperfusion in rats through TTC staining.
Figure 1(a) shows typical photographs of coronal sections
of the sham-operated, solvent-(distilled water) treated, and
THSWT-treated groups (0.7 and 1.4gkg
−1day
−1)p r i o rt o4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀects of Tao-Hong-Si-Wu-Tang (THSWT) in middle cerebral artery occlusion-(MCAO-) induced focal cerebral ischemia in
rats. (a) Coronal sections of 2,3,5-triphenyltetrazolium-(TTC-) stained brains, (b) dose-response eﬀect of THSWT, and (c) the infarct area
at various distances from the frontal pole 24h after MACO-reperfusion rats. Cerebral infarction in sham-operated (sham) or MACO-
reperfusion rats is from a representative animal that received the solvent (distilled water) or THSWT (0.7 and 1.4gkg
−1day
−1)o r a l l yf o r1 4
days. (a) TTC-stained brains and (b) infarct volumes were calculated as described in “Methods”, and data are presented as the infarct volume
for each animal in the group as well as the means ± S.E.M. (n = 7). ∗∗∗P<. 001, compared to the sham-operated group. (c) Forebrain
proﬁles of the infarct area at various distances from the frontal pole as described in “Methods”. Each point ( , solvent-treated group; Δ,
THSWT 0.7g kg
−1day
−1-treated group) and vertical bar represent the means±S.E.M. (n = 7). ∗P<. 05 and ∗∗∗P<. 001, compared to the
solvent-treated group.
the ischemic insult. Administration of THSWT at 0.7 and
1.4gkg
−1day
−1 showeddose-dependentreductionsininfarct
volume (white area) compared to the solvent-treated group
(solvent, 23.4% ± 0.6% versus 0.7gkg
−1day
−1,1 8 .9% ±
0.8%; 1.4gkg
−1day
−1,8 .2% ± 0.3%, n = 7) (Figure 1(b)).
Figure 1(c) gives statistical results of the infarct areas of
solvent- and THSWT-(0.7gkg
−1day
−1) treated groups at
various distances from the frontal pole. The infarct area
was largest between the 3rd and 4th sections in both
groups. Oral administration of THSWT (0.7gkg
−1day
−1)
markedly reduced the infarct area in all regions, especially in
sections three to ﬁve (Figure 1(c)). In addition, an obvious
improvement was observed in neurological function of
THSWT-(0.7gkg
−1day
−1) treated rats at 24h after MCAO
than that of solvent-treated group (1.3±0.4v e r s u s3 .2±0.7,
n = 7; P<. 05).
3.2. Inhibition of HIF-1α, iNOS, TNF-α, and Active Caspase-3
Expressions by THSWT in Ischemic Cerebral Tissues. Results
of immunoblotting of MCAO-insulted cerebral tissues are
shown in Figures 2 and 3. As shown in Figure 2(a),H I F - 1 α,
detected as a major band of approximately 120kDa 24h afterEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀects of Tao-Hong-Si-Wu-Tang (THSWT) on the expressions of (a) hypoxia-inducible factor (HIF-1α and (b) inducible nitric
oxide synthase (iNOS) in cerebral homogenates 24h after middle cerebral artery occlusion-(MCAO-) reperfusion injury in rats. Fresh brains
from sham-operated (lane 1), solvent-treated (lane 2), and THSWT- (0.7g kg
−1day
−1) treated (lane 3) rats were removed and sectioned
coronally into four sequential parts from the frontal lobe to the occipital lobe. The third of four sequential parts of the ischemic-injured
hemisphere was separately collected, homogenized, and centrifuged. The supernatant (50μg protein) was then subjected to SDS-PAGE,
and transferred onto membranes for analysis of HIF-1α and iNOS expressions. The results are representative examples of three similar
experiments. Data are presented as the means±S.E.M. ∗P<. 05 and ∗∗P<. 01, compared to the sham-operated group (lane 1). Equal
loading in each lane is demonstrated by similar intensities of α-tubulin.
MCAO-reperfusion injury (lane 2), was more pronounced
than that of levels obtained in the corresponding area of
thesham-operatedgroup(lane1).THSWT(0.7gkg
−1day
−1)
treatment signiﬁcantly (P<. 05) suppressed the expression
of HIF-1α in ischemic cerebral tissues (Figure 2(a),l a n e
3). In Figure 2(b), the iNOS band, detected as a major
band of approximately 135kDa, showed signiﬁcant increases
in ischemic cerebral tissues 24h after MCAO-reperfusion
compared to that of sham-operated rats. With oral admin-
istration of THSWT (0.7gkg −1day
−1), iNOS expression was
markedly reduced in MCAO-reperfused rats (Figure 2(b)).
In addition, negative immunostaining was obtained for
TNF-α in the sham-operated group (Figure 3(a),l a n e1 ) .
At 24 h after MCAO-reperfusion, strong staining of TNF-α
was observed in ischemic cerebral tissues (lane 2) compared
to levels obtained in the corresponding area of the sham-
operated group (lane 1). Again, THSWT (0.7gkg
−1day
−1)
obviouslyabolishedtheelevationofTNF-α(Figure 3(a),lane
3). Transient MCAO resulted in a signiﬁcant increase in the
expression of active caspase-3 (17kDa) in the injured hemi-
spherecomparedtolevelsobtainedinthecorrespondingarea
of the sham-operated group (Figure 3(b),l a n e2 ) .T H S W T
(0.7gkg
−1day
−1) treatment markedly reduced this reaction
(Figure 3(b),l a n e3 ) .
3.3. Eﬀects of THSWT on Platelet Aggregation In Vitro and
Thrombus Formation in Microvessels of Fluorescein Sodium-
Pretreated Mice In Vivo. Collagen (1μgmL
−1)t r i g g e r sa
more-pronounced platelet aggregation in washed platelet
suspensions (Figure 4(a)). THSWT (10∼40μgmL
−1)
concentration-dependently inhibited platelet aggregation
stimulated by collagen (1μgmL
−1). At 40μgmL
−1,T H S W T
almost inhibited platelet aggregation stimulated by collagen
(1μgmL
−1) in washed human platelets (Figure 4(a)). The
solvent control (Tyrode’s solution) did not signiﬁcantly
aﬀect platelet aggregation in this reaction (data not shown).
For the study of thrombus formation in microvessels of
ﬂuorescein sodium (15μgkg
−1)-pretreated mice, the time
to occlusion was approximately 140s. When THSWT was
administered at 16gkg
−1 after pretreatment with ﬂuorescein
sodium,occlusiontimesweremarkedlyprolongedcompared
to the solvent controls (normal saline, 139.3 ± 10.0sversus
16gkg
−1, 182.7 ±10.1s,n = 4, P<. 01) (Figure 4(b)).
3.4. Inhibition of Hydroxyl Radical (OH
•) Formation by
THSWT in ESR Spectrometry. In this study, typical ESR
signals of hydroxyl radicals (OH
•) were observed as shown
in Figure 5.T H S W T( 2 0a n d4 0 μgmL
−1) did not signiﬁ-
cantly suppress hydroxyl radical formation compared to the6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀects of Tao-Hong-Si-Wu-Tang (THSWT) on the expressions of (a) tumor necrosis factor (TNF)-α and (b) active caspase-3 in
cerebral homogenates 24h after middle cerebral artery occlusion-(MCAO-) reperfusion injury in rats. Fresh brains from sham-operated
(lane 1), solvent-treated (lane 2), and THSWT (0.7g kg
−1day
−1)-treated (lane 3) rats were removed and sectioned coronally into four
sequential parts from the frontal lobe to the occipital lobe. The third of four sequential parts of the ischemic-injured hemisphere was
separately collected, homogenized, and centrifuged. The supernatant (50μg protein) was then subjected to SDS-PAGE and transferred onto
membranes for analysis of TNF-α and active caspase-3 expressions. The results are representative examples of three similar experiments.
Data are presented as the means±S.E.M. ∗P<. 05 and ∗∗P<. 01, compared to the sham-operated group (lane 1). Equal loading in each
lane is demonstrated by similar intensities of α-tubulin.
solvent-treated group. This observation provides direct evi-
dence suggesting that the neuroprotective eﬀect of THSWT
was not mediated by free radical-scavenging activity.
4. Discussion
This study demonstrates for the ﬁrst time that THSWT
possesses neuroprotective activity against MCAO-induced
cerebral infarction in rats. Cerebral ischemia restricted to
the distribution of the MCAO gives rise to focal metabolic
disturbances that result in infarction, neuronal necrosis,
and brain edema [20]. MCAO-reperfusion injury induces
HIF-1α,i N O S ,T N F - α, and active caspase-3 expressions,
which may represent the response of neurons suﬀering from
ischemic insult. Animal models of focal cerebral ischemia,
for which MCAO is usually used, reproduce the pattern of
ischemic brain damage observed in many human ischemic
stroke patients [21].
The increased HIF-1α protein level observed after
MCAO-reperfusion is presumably induced by a loss of the
oxygen supply [21], resulting in a greater extent of binding
activity to the iNOS gene which produces a consequent
peak of iNOS protein expression. Since the iNOS gene
contains the hypoxia-responsive enhancer (HRE) sequence
to which HIF-1α binds [22], results from primary neuronal
cultures of cells demonstrated that HIF-1α binds to the
iNOS promoter gene under hypoxic conditions. Such
binding is associated with an increase in iNOS expression
[23]( Figure 6). Furthermore, HIF-1α combining with
p53 may promote apoptotic cell death in ischemic areas
[22]. In addition, the increased expression of iNOS may
also contribute to enhanced neuronal injury, since iNOS
knockout mice show reduced brain damage after ischemia
[24].
Several apoptosis-related proteins, including caspases-9
and -3, were all strongly expressed after ischemic injury. In
addition, hypoxia may cause HIF-1α to bind to p53 in order
to stabilize it, and also activates the expression of various
genes including Bax (a proapoptotic member of the Bcl-2
family) [25]. Bax is translocated to mitochondria where it
releases cytochrome c into the cytosol to interact with Apaf-
1 to activate caspase-9, which in turn activates downstream
caspases, such as active caspase-3 [26]. In the present
study, we showed that elevations of active caspase-3 and
iNOS expressions occurred in the same time frame as HIF-
1α expression after ischemic injury, and these expressions
could be signiﬁcantly suppressed by THSWT (Figure 6).
In addition, TNF-α is one of the key immunomodulatory
and proinﬂammatory cytokines upregulated during brain
ischemia [27]. Administration of TNF-α during ischemicEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Inhibitory eﬀect of Tao-Hong-Si-Wu-Tang (THSWT) on platelet aggregation in vitro and prolongation of the occlusion time
for inducing thrombus formation in vivo. (a) Washed human platelets (3.6 × 108 platelets mL
−1) were preincubated with THSWT (20
and 40μgml
−1) for 3min, followed by the addition of collagen (1μgmL
−1) to trigger platelet aggregation. The proﬁles are a representative
example of three similar experiments. (b) Mice were administered the solvent control (normal saline) or THSWT (3.2 and 16gkg
−1), after
which mesenteric venules were selected for irradiation to induce microthrombus formation. Data of the bar graphs in (b) are presented as
the means±S.E.M. of the occlusion time (s) for inducing platelet plug formation (n = 4). ∗∗P<. 01, compared to the individual solvent
control group.
brain insult was shown to augment injury, as evidenced
by increased tissue damage and neurological deﬁcits [28].
In addition to inﬂammation, TNF-α was also shown to be
involved in apoptosis [28]. In this study, we demonstrated
that THSWT can inhibit TNF-α expression during brain
ischemia.Therefore,inhibitionofactivecaspase-3expression
by THSWT may occur, at least partially, through the
inhibition of TNF-α expression in ischemic brain injury
(Figure 6).
Platelet aggregation plays a pathophysiological role in
cerebrovascular disorders. Inhibition of platelet aggregation
by drugs may represent an increased therapeutic possibility
for such diseases. We previously demonstrated that endothe-
lial cell injury induces platelet aggregation and adhesion to
vessel walls [29]. In the present study, we found that THSWT
inhibited both platelet aggregation in vitro and thrombosis
in vivo. In the thrombotic study, the mesenteric venules were
continuously irradiated by ﬂuorescein sodium throughout8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Inhibition of the free radical-scavenging activity by Tao-
Hong-Si-Wu-Tang (THSWT) in the H2O2/NaOH/DMSO system.
The signal of hydroxyl radical peaks was observed in electron
spin resonance (ESR) experiments. (a) Resting spectrum (without
H2O2), (b) typical ESR spectra in the presence of solvent control
(distilled water), (c) THSWT (20μgmL
−1), and (d) (40μgml
−1)i n
the H2O2/NaOH/DMSO system. The spectrum is a representative
example of four similar experiments. An asterisk (∗) indicates
formation of hydroxyl radicals.
the entire experimental period, thus leading to strong dam-
age to endothelial cells as previously described [30]. There-
fore, the dose (16gkg
−1) of THSWT employed in this model
was relatively higher than that (0.7gkg
−1day
−1)i nM C A O -
induced cerebral ischemia. Furthermore, we also examined
whether THSWT has direct free radical-scavenging activity
in a cell-free system. In this study, the mechanisms of free
radical formation in the H2O2/NaOH/DMSO system were
assumed to be from superoxide anions and hydroxyl radicals
being generated from the degradation of hydrogen peroxide
[19]. The superoxide anion changes into a hydroxyl radical
by the catalytic action of contaminating trace iron, so that
the amount of hydroxyl radicals is consequently relatively
larger than that of superoxide anions. Using this system, the
free radical-scavenging activity of hydroxyl radicals could
be evaluated. In this study, THSWT did not signiﬁcantly
inhibit hydroxyl radical formation in vitro. Thus, the neuro-
protection of THSWT might not involve, at least partly, the
inhibition of free radical formation.
In conclusion, the most important ﬁndings of this
study suggest that the neuroprotective eﬀect of THSWT
on cerebral ischemic damage in MCAO-reperfusion rats is
probably mediated by the inhibition of HIF-1α and TNF-α,
followed by the inhibition of inﬂammatory responses (i.e.,
iNOS), apoptosis (active caspase-3), and platelet activation.
The rationale for the use of THSWT is based on the fact
that multiple deleterious processes in diﬀerent cell types of
organelles are initiated during ischemia-reperfusion injury
which ultimately synergistically moves toward irreversible
injury. Therefore, treatment with THSWT is not limited to
one factor but involves many mechanisms, most of which
MCAO
Cerebral ischemia
HIF-1α
HIF-1α
Caspase-3
iNOS
NO
Inﬂammation
Apoptosis
Cell damage
Cerebral infarction
TNF-α
Figure 6: Hypothetical scheme of middle cerebral artery occlusion-
(MCAO-) induced focal cerebral ischemia. MCAO decreases the
blood ﬂow of ischemic area followed by inducing a release of
transcription factor HIF-1α.H I F - 1 α translocates into the nucleus
in activating genes of iNOS and TNF-α. iNOS may contribute
to enhance the inﬂammatory responses by elevating nitric oxide
(NO). TNF-α, it shows to be involved in apoptosis through the
activation of downstream caspases-3, and subsequently induces
cerebral infarction.
may be interrelated. For example, THSWT-induced neuro-
protection is related to inﬂammation, NO, and apoptosis,
and many of those factors (such as iNOS, active caspase-3,
etc.) are related to HIF-1α. We speculate that the suppression
of these molecules and morphological changes may lead to
improvements in patients with ischemic stroke. Thus, these
results provide scientiﬁc validation of a better understanding
of the eﬀectiveness of THSWT in ischemia-reperfusion brain
injury and related diseases.
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